A Japanese case report of co-localized psoriasis and vitiligo reveals that IL-23 blockade cleared psoriasis but not vitiligo, ...

While dermatologists prescribe coal tar shampoos for specific scalp conditions, it’s important to understand when and how ...

Arcutis Biotherapeutics, Inc. announced data presented across its ZORYVE® (roflumilast) portfolio as well as real-world research on the long-term use of topical corticosteroids at the 35thEuropean ...

Multi-country discrete-choice experiment presented at the Fall Clinical Dermatology Conference demonstrates that skin ...

Johnson & Johnson (NYSE: JNJ) today announced new two-year results from the Phase 3 ICONIC-LEAD a  study evaluating ICOTYDE ®  (icotrokinra), the first and only targeted oral peptide that precisely ...

Presentation of data from the INTEGUMENT-INFANT trial of investigational ZORYVE cream 0.05% in infants ages 3 to <24 months, where treatment ...

A new NHANES-based study of 11,668 US adults finds that a higher red blood cell distribution width-to-albumin ratio is ...

Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...

WESTLAKE VILLAGE - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced that ZORYVE ...

I’ve had psoriasis since I was 5 years old. It started as a little patch on my left ankle—I remember thinking, What’s this ...

Newly created award category highlights innovation in prescription skin treatmentZORYVE cream 0.15% for mild to moderate atopic dermatitis ...

Zasocitinib was 2.5 times more effective than deucravacitinib at helping patients with plaque psoriasis achieve completely clear skin, based on the first head-to-head test.